BioSpace News Archive

Press Releases

NeOnc Technologies Announces FDA End of Phase 1 Meeting for NEO212

September 28, 2026
·
4 min read
Press Releases

Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 21, 2026

September 28, 2026
·
1 min read
Press Releases

Mirum Pharmaceuticals Announces Primary Endpoint Met in Phase 3 AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta Virus

September 28, 2026
·
12 min read
Press Releases

LIB Therapeutics and Sun Pharma Announce Global Licensing, Commercialization and Manufacturing Agreement for Lerodalcibep, a Novel PCSK9 Inhibitor, Ex-US and China; Lerodalcibep (Lyrokaul®) Approved in the EU

September 28, 2026
·
7 min read
Press Releases

U.S. FDA Accepts sNDA and Grants Priority Review to Bayer’s Lynkuet® (elinzanetant) for a New Indication for the Treatment of Moderate to Severe Vasomotor Symptoms Due to Endocrine Therapy Related to Breast Cancer

September 28, 2026
·
9 min read
Press Releases

Circle Pharma Strengthens Leadership Team with Promotion of Marie Evangelista, Ph.D., to Chief Scientific Officer and Addition of Mary Ellen Sillivos as SVP and Head of Human Resources

September 28, 2026
·
3 min read
Press Releases

Tolerance Bio Licenses Clinical-Stage Anti-IL-33 Monoclonal Antibody from Tanabe Pharma to Expand Thymus-Focused Clinical Pipeline

September 28, 2026
·
5 min read
Press Releases

Vasomune Therapeutics Completes Enrollment of Phase 2a Study of Pegevongitide (AV-001) in Patients Hospitalized with Pneumonia/ARDS

September 28, 2026
·
4 min read
Press Releases

Lifecore Biomedical to be Acquired by Webster Equity Partners

September 28, 2026
·
16 min read
Press Releases

Palisade Bio to Present Clinical and Translational Data for PALI-2108 in Ulcerative Colitis and Crohn’s Disease at UEG Week 2026

September 28, 2026
·
6 min read